Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Cell Mol Life Sci. 2018 Oct 16;76(2):283–300. doi: 10.1007/s00018-018-2934-5

TABLE 1: CEREBROVASCULAR DISEASES AND ASSOCIATED GENES.

List of diseases, associated genes with chromosomal localization, pattern of inheritance, function of encoded proteins, and main references are given. AD: autosomal dominant. APP: amyloid precursor protein. AR: autosomal recessive. BRCC3: BRCA1/BRCA2-containing complex subunit 3. BRI2: integral membrane protein 2B. CAA: cerebral amyloid angiopathy. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. CARASIL: cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. CCM: cerebral cavernous malformations. CDKN2A-B: cyclin-dependent kinase inhibitor 2A-B. CNNM2: cyclin M2. CRV: cerebroretinal vasculopathy. CST3: cystatin C. EDNRA: endothelin receptor type A. GSN: gelsolin. GUCY1A3: guanylate cyclase soluble subunit alpha-3. HTRA1: high-temperature requirement A serine peptidase 1. IA: intracranial aneurysms. KL/STARD13: Klotho/StAR related lipid transfer domain containing 13. KRIT1: Krev1 interaction trapped gene 1. MMD: Moyamoya disease. NOTCH3: neurogenic locus notch homolog protein 3. PDCD10: programmed cell death protein 10. RBBP8: retinoblastoma binding protein 8. RNF213: ring finger protein 213. SOX17: SRY-related HMG-box family member 17. TTR: transthyretin. TREX1: three prime repair exonuclease 1. XR: X-linked recessive.

Disease Gene Chromosome Inheritance Function Reference
Hemorrhagic Disease
CCM1/KRIT1 7q AD controlling endothelial barrier junctions Laberge-le Couteulx et al., 1999 [44]
CCM CCM2 7p AD controlling endothelial barrier junctions Liquori et al., 2003 [45]
Denier et al., 2004 [46]
CCM3/PDCD10 3q AD induction of apoptosis; broadly expressed Bergametti et al., 2005 [47]
Guclu et al., 2005 [48]
SOX17 8q - maintenance of arterial integrity Bilguvar et al., 2008 [139]
Yasuno et al., 2010 [140]
CDKN2A-B 9p - cell growth regulator Bilguvar et al., 2008 [139]
Yasuno et al., 2010 [140]
Leeper et al., 2013 [145]
IA CNNM2 10q - unknown Yasuno et al., 2010 [140]
KL/STARD13 13q - unknown/cell proliferation Yasuno et al., 2010[140]
RBBP8 18q - cell cycle progression Yasuno et al., 2010 [140]
EDNRA 4q - vasoconstriction Yasuno et al., 2011 [141]
RNF213 17q AD angiogenic response to inflammation Kamada et al., 2011 [159]
Liu et al., 2011 [160]
MMD GUCY1A3 4q AR subunit of the major NO-receptor in the vascular wall Herve et al., 2014 [169]
BRCC3 Xq XR proper angiogenesis Miskinyte et al., 2011 [170]
Small Vessel Disease
CADASIL NOTCH3 19q AD cell fate; stability of vascular smooth muscle cells Joutel et al., 1996 [182]
CARASIL HTRA1 10q AR serine protease; regulation of TGFβ signaling Hara et al., 2009 [183]
APP 21q AD multiple; primary function unknown Rovelet-Lecrux et al., 2006 [245]
BRI2 13q AD unknown Vidal et al., 1999 [253]
CAA CST3 20p AD cysteine protease inhibitor Ghiso et al., 1986 [249]
TTR 18q AD transportation of thyroxine and retinol-binding protein Brett et al., 1999 [250]
GSN 9q AD actin filament dynamics Ghiso et al., 1990 [251]
CRV TREX1 3p AD maintenance of vascular integrity Richards et al., 2007 [184]